Tumefactive demyelinating disease treated with decompressive craniectomy

European Journal of Neurology

Volumn 16, Issue 5, 2009, Pages 639-642

  Nilsson, P ^a,b   Larsson, E M ^c   Kahlon, B ^b   Nordstrom C H ^b   Norrving, B ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Craniectomy; Tumefactive MS

Indexed keywords

ACICLOVIR; ALBUMIN; BETAMETHASONE; CEFOTAXIME; CORTICOSTEROID DERIVATIVE; DOXYCYCLINE; METRONIDAZOLE;

ADULT; ANAMNESIS; ARTICLE; BRAIN BIOPSY; BRAIN DAMAGE; BRAIN DECOMPRESSION; BRAIN EDEMA; CASE REPORT; CEREBROSPINAL FLUID EXAMINATION; CLINICAL FEATURE; CRANIECTOMY; DEMYELINATING DISEASE; DRUG DOSE REDUCTION; DRUG MEGADOSE; DYSPHASIA; FEMALE; FRONTAL LOBE; HUMAN; HUMAN TISSUE; LYME DISEASE; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESIS; PRIORITY JOURNAL; SEIZURE; SEROLOGY; TREATMENT OUTCOME; TUMEFACTIVE DEMYELINATING DISEASE; WHITE MATTER;

ADRENAL CORTEX HORMONES; BRAIN; CRANIOTOMY; DECOMPRESSION, SURGICAL; DEMYELINATING DISEASES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LYME NEUROBORRELIOSIS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED;

EID: 64149125586     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2009.02547.x     Document Type: Article

References (12)

1. Walther SM, Jonasson U, Gill H. Comparison of the Glasgow Coma Scale and the Reaction Level Scale for assessment of cerebral responsiveness in the critically ill. Intensive Care Med 2003 29 : 933 938.
2. Masdeu JC, Quinto C, Olivera C, Tenner M, Leslie D, Visintainer P. Open-ring imaging sign: highly specific for atypical brain demyelination. Neurology 2000 54 : 1427 1433.
3. Tan HM, Chan LL, Chuah KL, Goh NS, Tang KK. Monophasic, solitary tumefactive demyelinating lesion: neuroimaging features and neuropathological diagnosis. Br J Radiol 2004 77 : 153 156.
4. Enzinger C, Strasser-Fuchs S, Ropele S, Kapeller P, Kleinert R, Fazekas F. Tumefactive demyelinating lesions: conventional and advanced magnetic resonance imaging. Mult Scler 2005 11 : 135 139.
5. Mao-Draayer Y, Braff S, Pendlebury W, Panitch H. Treatment of steroid-unresponsive tumefactive demyelinating disease with plasma exchange. Neurology 2002 59 : 1074 1077.
6. Weinshenker BG, O'Brien PC, Petterson TM, et al. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol 1999 46 : 878 886.
7. Vahedi K, Hofmeijer J, Juettler E, et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol 2007 6 : 215 222.
8. Ragel BT, Fassett DR, Baringer JR, Browd SR, Dailey AT. Decompressive hemicraniectomy for tumefactive demyeliniation with transtentorial herniation: observation. Surg Neurol 2006 65 : 582 583.
9. Censori B, Agostinis C, Partziguian T, Gazzaniga G, Biroli F, Mamoli A. Large demyelinating brain lesion mimicking a herniating tumor. Neurol Sci 2001 22 : 325 329.
10. Refai D, Lee MC, Goldenberg FD, Frank JI. Decompressive hemicraniectomy for acute disseminated encephalomyelitis: case report. Neurosurgery 2005 56 : E872.
11. Von Stuckrad-Barre S, Klippel E, Foerch C, Lang JM, du Mesnil de Rochemont R, Sitzer M. Hemicraniectomy as a successful treatment of mass effect in acute disseminated encephalomyelitis. Neurology 2003 61 : 420 421.
12. González Sánchez JJ, Ensenyat Nora J, de Notaris M, Rumiá Arboix J, Garcla-Amorena Garcla C, Ferrer RodrIguezE. A case of malignant monophasic multiple sclerosis (Marburg's disease type) successfully treated with decompressive hemicraniectomy. J Neurol Neurosurg Psychiatry 2008 [Epub ahead of print].